| ACOR |    | Acorda Therapeutics, Inc. - Common Stock | | | up -26.09% 26.09 | | + Disease: Neurology/Alzheimer/Parkinson's, Medicine, Biotechnology
Last highlighted: Form 8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain.. $ACOR https://t.co/pzylSpmKBK | + My List |
| APTO | | Aptose Biosciences, Inc. - Common Shares | | | -1.79% -1.79% 0 | | + Biotechnology
| + My List |
| APVO | | Aptevo Therapeutics Inc. - Common Stock | | | 5% down 18.12% -13.12 | | + Biotechnology, Medicine, Disease: Oncology, Immunology
Last highlighted: $APVTW [15s. delayed] filed form 8-K on May 27, 09:02:28: Item7.01: Regulation FD https://t.co/MpE2r05xab | + My List |
| BNTC | | Benitec Biopharma Inc. - Common Stock | | | -10.74% -10.74% 0 | | + Biopharma, Biotechnology, RNA, Medicine, Gene and cell
Last highlighted: Form 8-K: Regulation FD Disclosure. On February 24, 2021, Benitec Biopharma issued a presentation on the results of the interim analysis.. $BNTC https://t.co/mayyXsnb9Q | + My List |
| BNTX | | BioNTech SE - American Depositary Shares | | | -1.57% down 8.99% -10.56 | | + Biotechnology, Immunology, Covid (fighting), Medicine
Last highlighted: #BNTX SEC report: BioNTech SE Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BioNTech SE -- SEC File Number 211142358 | + My List |
| CYCC | | Cyclacel Pharmaceuticals, Inc. - Common Stock | | | 2.21% down 7.75% -5.54 | | + Biotechnology, Biopharma, Pharmaceutical , Medicine, Gene and cell
- Bad infrastructure
| + My List |
| DARE | | Dare Bioscience, Inc. - Common Stock | | | -1.74% down 10.78% -12.52 | | + Biotechnology, Healthcare, Women Health
Last highlighted: SEC Form 8-K [Press/News Current Report] filed by $DARE Dare Bioscience, Inc. https://t.co/iSB0Q2Ucpd | + My List |
| ENTX | | Entera Bio Ltd. - Ordinary Shares | | | 6.31% 6.31% 0 | | + Country: Israel, Biotechnology, Pharmaceutical
Last highlighted: $ENTX 📜 SEC Form 6-K filed by Entera Bio Ltd.
https://t.co/dws8IKVGAV
#healthcare | + My List |
| ENTXW | | Entera Bio Ltd. - Warrant | | | 0 | | + Country: Israel, Biotechnology, Pharmaceutical
| + My List |
| FBIO | | Fortress Biotech, Inc. - Common Stock | | | -6.73% up -8.65% 1.92 | | + Pharmaceutical , Biopharma, Biotechnology, Medicine
| + My List |
| FBIOP | | Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | | | 0.52% 0.52% 0 | | + Medicine, Biotechnology, Biopharma
| + My List |
| FLDM | | Fluidigm Corporation - Common Stock | | | -7.02% -7.02% 0 | | + Life Sciences, Biology, Cancer fight, Biotechnology, RNA
Last highlighted: #FLDM SEC report: FLUIDIGM CORP Current report, items 1.01, 2.03, and 9.01
SEC Filing Form 8-K filed by FLUIDIGM CORP -- SEC File Number 211148270 | + My List |
| FRLN | | Freeline Therapeutics Holdings plc - ADSs | | | -7.84% -7.84% 0 | | + Medicine, Biotechnology, Gene and cell
| + My List |
| GLYC | | GlycoMimetics, Inc. - Common Stock | | | up -8% 8 | | + Biotechnology, Medicine, Disease: Leukemia
| + My List |
| IGMS | | IGM Biosciences, Inc. - Common Stock | | | -0.42% down 8.83% -9.25 | | + Biotechnology, Gene and cell, Medicine
Last highlighted: #IGMS SEC report: IGM Biosciences, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by IGM Biosciences, Inc. -- SEC File Number | + My List |
| IMNM | | Immunome, Inc. - Common Stock | | | 2.9% down 12.24% -9.34 | | + Cancer fight, Biotechnology, Medicine, Immunology
| + My List |
| IMRN | | Immuron Limited - American Depositary Shares | | | 5.86% 5.86% 0 | | + Biotechnology, Country: Australia, Biopharma, Medicine
Last highlighted: $IMRN 📜 SEC Form 6-K filed by Immuron Limited
https://t.co/xsrBOQcQ0a | + My List |
| IOVA | | Iovance Biotherapeutics, Inc. - Common Stock | | | 1.15% down 8.46% -7.31 | | + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based
Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127 | + My List |
| KIN | | Kindred Biosciences, Inc. - Common Stock | | | 45.43% down 45.74% -0.31 | | + Animals, Biopharma, Biotechnology, Medicine, Pets
Last highlighted: #KIN SEC report: Kindred Biosciences, Inc. Definitive proxy statement relating to merger or acquisition
SEC Filing Form DEFM14A filed by Kindred Biosciences, Inc. -- SEC File Number 211102924 | + My List |
| LRMR | | Larimar Therapeutics, Inc. - Common Stock | | | -0.78% up -7.91% 7.13 | | + Medicine, Gene and cell, Biotechnology
| + My List |
| MBRX | | Moleculin Biotech, Inc. - Common Stock | | | -7.58% -7.58% 0 | | + Biotechnology, Pharmaceutical , Medicine, Cancer fight, Disease: Infectious
Last highlighted: #MBRX SEC report: Moleculin Biotech, Inc. Statement of changes in beneficial ownership of securities | + My List |
| MCRB | | Seres Therapeutics, Inc. - Common Stock | | | 5.41% up -10.35% 15.76 | | + Medicine, Microbiome, Biotechnology
Last highlighted: #MCRB SEC report: Seres Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Seres Therapeutics, Inc. -- SEC File Number 211137957 | + My List |
| NRIX | | Nurix Therapeutics, Inc. - Common stock | | | -1.03% down 9.91% -10.94 | | + Biotechnology, Cancer fight, Immunology
Last highlighted: #NRIX SEC report: Nurix Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Nurix Therapeutics, Inc. -- SEC File Number 211088020 | + My List |
| NTLA | | Intellia Therapeutics, Inc. - Common Stock | | | -4.32% down 10.42% -14.74 | | + Medicine, Gene and cell, Biotechnology, Biopharma
| + My List |
| OMER | | Omeros Corporation - Common Stock | | | 3.56% down 17.06% -13.5 | | + Biopharma, Biotechnology, Medicine
Last highlighted: #OMER SEC report: OMEROS CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by OMEROS CORP -- SEC File Number | + My List |
| ONCR | | Oncorus, Inc. - Common Stock | | | 14.75% down 17.31% -2.56 | | + Cancer fight, Immunology, Biotechnology
Last highlighted: #ONCR SEC report: Oncorus, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Oncorus, Inc. -- SEC File Number 211142316 | + My List |
| ORGS | | Orgenesis Inc. - Common Stock | | | -8.26% -8.26% 0 | | + Biotechnology, Medicine, Gene and cell
Last highlighted: Filing Alert, FORM 10-Q [Quarterly Report] available. $ORGS #Orgenesis Inc. Orgenesis Inc https://t.co/cwDFhLgUnk | + My List |
| PDSB | | PDS Biotechnology Corporation - Common Stock | | | 3.28% down 11.36% -8.08 | | + Biotechnology, Immunology, Cancer fight, Disease: Oncology, Medicine
Last highlighted: RT @EdgarInsider: FORM 8-K [Press/News Current Report] recently SEC filed. $PDSB $EDGE PDS Biotechnology Corp https://t.co/FKxSQ3btJT | + My List |
| PRQR | | ProQR Therapeutics N.V. - Ordinary Shares | | | -6% up -7% 1 | | + Medicine, Biotechnology, Disease: Eye , RNA
| + My List |
| QRVO | | Qorvo, Inc. - Common Stock | | | 5% down 7.08% -2.08 | | + Semiconductor, Biotechnology, Diagnosing, IoT, 5G, Mobile, Network Infrastructure, Equipment
| + My List |
| RGNX | | REGENXBIO Inc. - Common Stock | | | -7.44% -7.44% 0 | | + Gene and cell, Biotechnology, Medicine
| + My List |
| RKDA | | Arcadia Biosciences, Inc. - Common Stock | | | 3.13% down 7.69% -4.56 | | + Agritech, Biotechnology
Last highlighted: #RKDA SEC report: Arcadia Biosciences, Inc. [Amend] Current report, item 9.01
SEC Filing Form 8-K/A filed by Arcadia Biosciences, Inc. -- SEC File Number 211136758 | + My List |
| RLMD | | Relmada Therapeutics, Inc. - Common Stock | | | -1.63% -1.63% 0 | | + Disease: Central nervous system (CNS), Biotechnology, Medicine
Last highlighted: $RLMD 📜 SEC Form 10-Q filed by Relmada Therapeutics, Inc.
https://t.co/CGB5BcamVJ
30s delayed. This insight appeared in real-time at 🚆 https://t.co/TvhaBDQJ0C 🚆 | + My List |
| RVMD | | Revolution Medicines, Inc. - Common Stock | | | -28.74% -28.74% 0 | | + Cancer fight, Medicine, Biotechnology
| + My List |
| SELB | | Selecta Biosciences, Inc. - Common Stock | | | up -9.71% 9.71 | | + Biotechnology, Immunology, Biology, Medicine
Last highlighted: $SELB Selecta Biosciences, Inc. SEC Filing: Form 8-K https://t.co/0XklTmmzMS | + My List |
| SLRX | | Salarius Pharmaceuticals, Inc. - Common Stock | | | 0 | | + Cancer fight, Biotechnology, Medicine, Pharmaceutical
Last highlighted: $SLRX 8-K Salarius Pharmaceuticals (8 Mar, 4:30pm)
📰 Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
https://t.co/AWdEx2wgvD
#SLRX #8K #SalariusPharmaceuticals #News | + My List |
| SNES | | SenesTech, Inc. - Common Stock | | | 0 | | + Biotechnology, Agritech
Last highlighted: $SNES SenesTech, Inc. (NASDAQ:SNES) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers https://t.co/6t4UWwGDlL | + My List |
| TWST | | Twist Bioscience Corporation - Common Stock | | | 0.45% up -7.15% 7.6 | | + Biotechnology, RNA, Medicine
Last highlighted: #TWST SEC report: Twist Bioscience Corp Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Twist Bioscience Corp -- SEC File Number | + My List |
| WVE | | Wave Life Sciences Ltd. - Ordinary Shares | | | -3.91% up -18.83% 14.92 | | + Medicine, Biotechnology, Life Sciences
| + My List |
| XOMA | | XOMA Corporation - Common Stock | | | up -7.03% 7.03 | | + Biotechnology, Medicine, Acquisitions/Investing
| + My List |
| YTEN | | Yield10 Bioscience, Inc. - Common Stock | | | 3.72% down 18.75% -15.03 | | + Biotechnology, Agritech, Food
| + My List |
| AGFY | | Agrify Corporation - Common Stock | | | -8.18% -8.18% 0 | | + Biotechnology, Cannabis, Farm, Agritech
| + My List |
| ENVB | | Enveric Biosciences, Inc. - Common Stock | | | -10.68% -10.68% 0 | | + Biotechnology, Cancer fight, Medicine, Cannabis, Disease: Oncology
Last highlighted: #ENVB SEC report: Enveric Biosciences, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Enveric Biosciences, Inc. -- SEC File Number 211084155 | + My List |
| EVAX | | Evaxion Biotech A/S - American Depositary Share | | | 6.15% down 7.45% -1.3 | | + Cancer fight, Disease: Oncology, Immunology, Medicine, Biotechnology, Biology
Last highlighted: #EVAX SEC report: Evaxion Biotech A/S Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Evaxion Biotech A/S -- SEC File Number 211078935 | + My List |
| GBS | | GBS Inc. - Common Stock | | | -6% up -8% 2 | | + Medicine, Biotechnology
| + My List |
| IDBA | | IDEX Biometrics ASA - American Depositary Shares | | | 3.75% down 7.74% -3.99 | | + Technology, Security, Biotechnology, Fingerprint
| + My List |
| LGVN | | Longeveron Inc. - common stock | | | 16.48% 16.48% 0 | | + Biotechnology, Medicine, Gene and cell, Disease: Neurology/Alzheimer/Parkinson's
| + My List |
| LIXT | | Lixte Biotechnology Holdings, Inc. - Common Stock | | | up -19.83% 19.83 | | + Biotechnology, Cancer fight, Disease: Oncology, Medicine
Last highlighted: #LIXT SEC report: LIXTE BIOTECHNOLOGY HOLDINGS, INC. Current report, item 5.07
SEC Filing Form 8-K filed by LIXTE BIOTECHNOLOGY HOLDINGS, INC. -- SEC File Number 211083663 | + My List |
| RXDX | | Prometheus Biosciences, Inc. - Common Stock | | | 1.71% down 11.42% -9.71 | | + Biotechnology, Medicine, Diagnosing, Immunology
| + My List |
| VRDN | | Viridian Therapeutics, Inc. - Common Stock | | | 0.00% 0 | | + Disease: Eye , Medicine, Biotechnology
Last highlighted: $VRDN 8-K/A Viridian Therapeutics (15 Jun, 5:30pm)
📰 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (amendment)
https://t.co/Ot2kOEW3mb
#VRDN #8KA #ViridianTherapeutics #News | + My List |